Meu SciELO
Serviços Personalizados
Journal
Artigo
Indicadores
Citado por SciELO
Acessos
Links relacionados
Citado por Google
Similares em SciELO
Similares em Google
Compartilhar
Anales de Medicina Interna
versão impressa ISSN 0212-7199
Resumo
GIMENO ORNA, J. A.; BONED JULIANI, B.; LOU ARNAL, L. M. e CASTRO ALONSO, F. J.. Glycaemic control related factors in type 2 diabetes mellitus patients. An. Med. Interna (Madrid) [online]. 2003, vol.20, n.3, pp.20-24. ISSN 0212-7199.
Objectives: To describe metabolic, lipidic and blood pressure control and to identify blood glucose control predictive factors in patients with type 2 diabetes. Material and methods: Retrospective cohort study. Ambulatory type 2 diabetic patients were selected from 2/1/00 to 14/11/01 if they had been visited yearly at least three years previously. They were classified into three groups: a) initial and final treatment with diet and/or oral glucose-lowering drugs; b) insulinized patients during follow-up; and c) initial and final therapy with insulin. Body mass index (BMI), blood pressure, HbA1c and lipid profile were determined at start and at the end of the study. A multiple regression model was used to predict mean HbA1c through follow-up. Results: 320 patients were selected , 199 women (62.2%) and 121 men (37.8%) with mean age of 69 years (SD: 9). Mean follow-up was 5.2 years (SD: 1.1). 106 patients (33.8%) were included into A group, 70 patients (22.4%) into B group and 137 (43.8%) into C group. 63% of patients had values of HbA1c >7.5%, 36% blood pressure >140/85 mmHg and 8.5% LDL values >155 mg/dl. HbA1c mean through follow-up was of 8.2% and its independent predictors were baseline HbA1c (0.37; IC 95% 0.31-0.43; p<0.001), baseline BMI (0.023; IC 95% 0.004-0.042; p=0.017), baseline treatment with insulin (0.67; IC 95% 0.45-0.88; p<0.001) and insulinization during follow-up (0.46; IC 95% 0.21-0.71; p<0.001). Conclusions: It's difficult to achieve an acceptable blood glucose control. Mean HbA1c predictive factors include baseline HbA1c and BMI and insulin therapy.
Palavras-chave : Type 2 diabetes; Metabolic control; Blood glucose control.